With decades of conflicting studies on low-dose atropine’s efficacy in treating myopia and no Medsafe-approved drop available, are our young myopes missing out?
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
An optometrist recounts her experience on an Eyes4Everest outreach trip to Nepal's Annapurna region, providing eyecare at high-altitude
Digital: from $40/year +GST
Print + Digital: $110/year +GST (adds print magazine, wallplanner, delivery)
Veteran Auckland optometrist Trevor Skinner retires after nearly 50 years, known for his patient-first approach, empathy, and passion for optometry, having
Artificial intelligence (AI) use in eyecare is moving fast, but are regulation, ethics and real-world integration keeping pace? As clinicians and regulators grapple with how to harness its potential without compromising patient safety or equity, Drew Jones examines where AI use in eyecare stands and
February is my favourite time of the year. Not only is there beautiful summer weather and warm seawater, but this is the time when the Australian and New Zealand Glaucoma Society (ANZGS) Congress takes place! This year’s meeting was in Sydney CBD’s Masonic Centre. It’s a fabulous venue with beautifu
In eyecare, some of the most life-changing diagnoses are also the most common. For clinicians, they sit within well‑worn management pathways. For patients, they often mean uncertainty, a loss of independence and perhaps even a life‑changing fear of blindness.
Hamilton-based vitreoretinal specialist Dr Stephen Guest explains how Optos’ ultra-widefield imaging technology is making a difference to his practice and his patients. By Lesley Springall for Optos.